Target intelligence / Profile preview

Host intestinal mucosal surfaces, epithelial cells, pathogens, and immune cells

Molecular classification
Other
01

Overview

The host intestinal mucosal surface represents a complex multi-layered system consisting of the intestinal epithelium, the overlying mucus layer, the resident microbiota, and the underlying gut-associated lymphoid tissue (GALT) (Mowat & Agace, 2014, Nature Reviews Immunology). This system serves as a critical interface between the external environment and the host's internal milieu, performing essential functions such as nutrient absorption and acting as a selective barrier against pathogens (Vancamelbeke & Vermeire, 2017, Therapeutic Advances in Gastroenterology). The epithelial cells provide a physical barrier maintained by tight junctions, while specialized immune cells monitor the environment to mount appropriate responses to threats (Okumura & Takeda, 2017, Nature Reviews Immunology). Pathogenic organisms can disrupt this balance, leading to infections or chronic inflammatory states like inflammatory bowel disease (IBD) (Ribet & Cossart, 2015, Microbes and Infection). Therapeutic strategies targeting this system often focus on specific molecular components within it, such as integrins involved in immune cell trafficking or cytokines that drive inflammation (Danese, 2012, Gut). Understanding the interplay between these various components is vital for developing treatments that restore mucosal homeostasis and barrier integrity.

Other names
Intestinal mucosal barrierGastrointestinal mucosal systemGut-associated lymphoid tissueGALTIntestinal microenvironment
02

Mechanism of action

Drugs targeting this system typically work by modulating immune cell recruitment, neutralizing inflammatory mediators, or altering the microbial environment to restore barrier function and homeostasis.

03

Biological functions

Immune responseBarrier functionNutrient absorptionPathogen defenseHomeostasis
04

Disease associations

Inflammatory bowel diseaseInfectionCeliac diseaseIrritable bowel syndromeColitis
05

Safety considerations

DysbiosisIncreased risk of opportunistic infectionsSystemic immunosuppressionMucosal atrophy
06

Interacting drugs

Vedolizumab

5 more in the full profile.

07

Biomarkers

Fecal calprotectinC-reactive proteinZonulinSerum citrulline

Beyond the preview

Go deeper on Host intestinal mucosal surfaces, epithelial cells, pathogens, and immune cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal mucosal surfaces, epithelial cells, pathogens, and immune cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call